Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New macrolides]

F Lecomte1, D Benhamou

  • 1Département de médecine interne, Hôpital de Boisguillaume, CHU, Rouen, France.

La Revue De Medecine Interne
|October 17, 1998
PubMed
Summary
This summary is machine-generated.

New macrolides offer improved pharmacokinetic profiles and efficacy for opportunistic infections like HIV-related conditions and H. pylori ulcers. Their favorable properties suggest a promising future in anti-infective strategies, including potential non-antibiotic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Education in obstetric anesthesiology: an international approach.

International journal of obstetric anesthesia·2023
Same author

Cephalad spread of a biopolymer used for aesthetic reshaping of the buttocks impeding the use of lumbar epidural anaesthesia.

Anaesthesia, critical care & pain medicine·2023
Same author

Neuraxial anesthesia for delivery in parturtients with Brugada syndrome: Local anesthetics revisited.

Journal of gynecology obstetrics and human reproduction·2023
Same author

Gynecologie, obstetrique, fertilite & senologie·2021
Same author

Real-life evaluation of the treatment of actinic keratoses by textile photodynamic therapy (FLUXMEDICARE® device).

Photodiagnosis and photodynamic therapy·2021
Same author

IRMPD spectroscopy and quantum chemistry calculations on mono- and bi-metallic complexes of acetylacetonate ligands with aluminum, iron, and ruthenium ions.

The Journal of chemical physics·2020
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • New macrolides (roxithromycin, clarithromycin, azithromycin, dirithromycin) are erythromycin derivatives with enhanced pharmacokinetic properties.
  • These agents exhibit improved oral administration, longer half-lives, better tissue penetration, and enhanced cellular concentrations compared to erythromycin.
  • Despite pharmacokinetic advantages, their antibacterial spectrum against common pyogenic strains is similar to erythromycin.

Purpose of the Study:

  • To assess the clinical utility and future prospects of new macrolide antibiotics.
  • To evaluate their role in treating opportunistic infections and specific bacterial infections like Helicobacter pylori.
  • To explore the potential of macrolides beyond their antibacterial effects.

Main Methods:

Related Experiment Videos

  • Review of existing literature on new macrolides.
  • Analysis of pharmacokinetic and pharmacodynamic data.
  • Evaluation of clinical applications and emerging therapeutic roles.

Main Results:

  • New macrolides demonstrate efficacy in treating opportunistic infections in HIV patients, including atypical mycobacterial infections and toxoplasmosis.
  • They are recommended for eradicating Helicobacter pylori in gastroduodenal ulcers.
  • Efficacy against Chlamydia pneumoniae suggests a role in vascular diseases.

Conclusions:

  • New macrolides represent advancements in anti-infective strategies.
  • Their efficacy against Chlamydia pneumoniae and potential non-antibiotic effects indicate a favorable future.
  • The development of related compounds like ketolides further supports the evolving role of macrolides.